stage iii colon cancer
Showing 1 - 25 of 28
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +
Not yet recruiting
- Stage I Colon Cancer
- +2 more
- Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
- +2 more
-
Houston, TexasBaylor College of Medicine
May 22, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)
Terminated
- POLE Exonuclease Mutant Colon Cancer
- +2 more
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Oct 5, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022
Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)
Active, not recruiting
- Stage III Colon Cancer
- Oxaliplatin
- Oxaliplatin LBM
-
Marseille, Bouches Du Rhône, France
- +10 more
Aug 2, 2022
Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)
Recruiting
- Stage III Colon Cancer
- Signatera test
- +5 more
-
Pittsburgh, PennsylvaniaNRG Oncology - Pittsburgh Center
Mar 30, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Adjuvant Therapy for Stage II-III Colon Cancer After Radical
Recruiting
- Stage II Colon Cancer
- +2 more
-
Nanjing, Jiangsu, China
- +2 more
Jul 14, 2021
Adenocarcinoma of the Colon, Stage III Colon Cancer Trial in Canada, Puerto Rico, United States (irinotecan HCl, oxaliplatin,
Completed
- Adenocarcinoma of the Colon
- Stage III Colon Cancer
- irinotecan hydrochloride
- +5 more
-
Anniston, Alabama
- +893 more
Apr 28, 2020
Stage II Colon Cancer, Stage III Colon Cancer Trial in Philadelphia (Exercise)
Completed
- Stage II Colon Cancer
- Stage III Colon Cancer
- Exercise
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 7, 2020
Stage III Colon Cancer Trial in Durham (AVX701)
Completed
- Stage III Colon Cancer
- AVX701
-
Durham, North CarolinaDuke University Medical Center
Jul 16, 2019
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Cleveland (questionnaire administration, laboratory
Completed
- Stage I Colon Cancer
- +5 more
- questionnaire administration
- +5 more
-
Cleveland, Ohio
- +1 more
Jul 19, 2018
Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma Trial in Winston-Salem (HIPEC Orientation,
Completed
- Advanced Malignant Mesothelioma
- +15 more
- HIPEC Orientation
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 2, 2018
Advanced Colorectal Adenomas, Adenocarcinoma of the Colon, Stage I Colon Cancer Trial in Chicago, Hines, Rochester (defined
Terminated
- Advanced Colorectal Adenomas
- +4 more
- defined green tea catechin extract
- +3 more
-
Chicago, Illinois
- +2 more
Sep 27, 2017
Stage III Colon Cancer Trial in Kaohsiung (tegafur-uracil)
Active, not recruiting
- Stage III Colon Cancer
-
Kaohsiung, TaiwanChung-Ho Memorial Hospital, Kaohsiung Medical University:
Feb 6, 2017
Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B
Completed
- Recurrent Colon Cancer
- +13 more
- Detox-B adjuvant
- ras peptide cancer vaccine
-
Bethesda, MarylandMedicine Branch
Apr 27, 2015
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Boston (biological, drug, other)
Completed
- Adenocarcinoma of the Colon
- +7 more
- pertuzumab
- +8 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 11, 2015
Stage III Colon Cancer Trial in Guagzhou (procedure, drug, biological)
Unknown status
- Stage III Colon Cancer
- Radical surgery
- +2 more
-
Guagzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Nov 3, 2014
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Stage I Colon Cancer Trial in Ann Arbor (resveratrol, pharmacological
Completed
- Adenocarcinoma of the Colon
- +7 more
- resveratrol
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Sep 12, 2014
Adenocarcinoma of the Colon, Stage III Colon Cancer Trial in Chicago (leucovorin calcium, fluorouracil, irinotecan HCl)
Completed
- Adenocarcinoma of the Colon
- Stage III Colon Cancer
- leucovorin calcium
- +3 more
-
Chicago, IllinoisCancer and Leukemia Group B
Oct 7, 2013
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage III Colon Cancer Trial in Buffalo (oxaliplatin, leucovorin calcium,
Completed
- Recurrent Colon Cancer
- +6 more
- oxaliplatin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 27, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia
Completed
- Adenocarcinoma of the Colon
- +41 more
- recombinant fowlpox-CEA(6D)/TRICOM vaccine
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 24, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in San Antonio (drug, biological, other)
Terminated
- Adenocarcinoma of the Colon
- +7 more
- oxaliplatin
- +5 more
-
San Antonio, TexasSouthwest Oncology Group
Jan 24, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Boston (bevacizumab, oxaliplatin,
Completed
- Adenocarcinoma of the Colon
- +7 more
- bevacizumab
- +3 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Jan 23, 2013